A phase 2 clinical trial of IONIS-ENAC-2.5Rx in patients with Cystic fibrosis not amenable to CFTR modulators
Latest Information Update: 30 May 2021
At a glance
- Drugs Cofirasersen (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 30 May 2021 New trial record